108 related articles for article (PubMed ID: 2068275)
1. Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines.
Cowan DS; Panicucci R; McClelland RA; Rauth AM
Radiat Res; 1991 Jul; 127(1):81-9. PubMed ID: 2068275
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities.
Cowan DS; Matejovic JF; Wardman P; McClelland RA; Rauth AM
Int J Radiat Biol; 1994 Dec; 66(6):729-38. PubMed ID: 7814971
[TBL] [Abstract][Full Text] [Related]
3. DNA-targeted 2-nitroimidazoles: studies of the influence of the phenanthridine-linked nitroimidazoles, 2-NLP-3 and 2-NLP-4, on DNA damage induced by ionizing radiation.
Buchko GW; Weinfeld M
Radiat Res; 2002 Sep; 158(3):302-10. PubMed ID: 12175307
[TBL] [Abstract][Full Text] [Related]
4. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin.
Panicucci R; Heal R; Laderoute K; Cowan D; McClelland RA; Rauth AM
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation.
Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM
Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693
[TBL] [Abstract][Full Text] [Related]
6. DNA-targeted 2-nitroimidazoles: in vitro and in vivo studies.
Cowan DS; Matejovic JF; McClelland RA; Rauth AM
Br J Cancer; 1994 Dec; 70(6):1067-74. PubMed ID: 7981056
[TBL] [Abstract][Full Text] [Related]
7. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD
Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a cell line resistant to 5-[3-(2-nitro-1-imidazoyl)-propyl]-phenanthridinium bromide (2-NLP-3), a DNA-intercalating hypoxic cell radiosensitizer and cytotoxin.
Cowan DS; McClelland RA; Rauth AM
Biochem Pharmacol; 1995 Jun; 50(1):61-8. PubMed ID: 7605346
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers.
Papadopoulou MV; Rosenzweig HS; Bloomer WD
Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395
[TBL] [Abstract][Full Text] [Related]
10. Platinum complexes with one radiosensitizing ligand [PtCl2(NH3) (sensitizer)]: radiosensitization and toxicity studies in vitro.
Skov KA; Farrell NP; Adomat H
Radiat Res; 1987 Nov; 112(2):273-82. PubMed ID: 3685256
[TBL] [Abstract][Full Text] [Related]
11. Multicellular membranes as an in vitro model for extravascular diffusion in tumours.
Cowan DS; Hicks KO; Wilson WR
Br J Cancer Suppl; 1996 Jul; 27():S28-31. PubMed ID: 8763841
[TBL] [Abstract][Full Text] [Related]
12. The phenanthridine biguanides efficiently differentiate between dGdC, dAdT and rArU sequences by two independent, sensitive spectroscopic methods.
Radić Stojković M; Miljanić S; Mišković K; Glavaš-Obrovac L; Piantanida I
Mol Biosyst; 2011 May; 7(5):1753-65. PubMed ID: 21431121
[TBL] [Abstract][Full Text] [Related]
13. Sequence specificity, enantiospecificity and polyelectrolyte effect in the binding to DNA of a 6-(2-pyridyl)phenanthridine chiral photonuclease.
Colmenarejo G; Montero F; Orellana G
Anticancer Drug Des; 1997 Jun; 12(4):239-60. PubMed ID: 9199658
[TBL] [Abstract][Full Text] [Related]
14. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
[TBL] [Abstract][Full Text] [Related]
15. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
Denny WA; Roberts PB; Anderson RF; Brown JM; Phil D; Wilson WR
Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.
Flockhart IR; Large P; Troup D; Malcolm SL; Marten TR
Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443
[TBL] [Abstract][Full Text] [Related]
17. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells.
Rockwell S; Irvin CG; Nierenburg M
Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.
Skov KA; Adomat H; Chaplin DJ; Farrell NP
Anticancer Drug Des; 1990 Feb; 5(1):121-8. PubMed ID: 2156514
[TBL] [Abstract][Full Text] [Related]
19. NMR determination of the hetero-association of phenanthridines with daunomycin and their competitive binding to a DNA oligomer.
Davies DB; Veselkov DA; Veselkov AN
Eur Biophys J; 2002 May; 31(2):153-62. PubMed ID: 12012119
[TBL] [Abstract][Full Text] [Related]
20. Iodoazomycin riboside (1-(5'-iodo-5'-deoxyribofuranosyl)-2-nitroimidazole), a hypoxic cell marker. I. Synthesis and in vitro characterization.
Jette DC; Wiebe LI; Flanagan RJ; Lee J; Chapman JD
Radiat Res; 1986 Feb; 105(2):169-79. PubMed ID: 3952269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
